Jay S. Duker
Director, Carisma Therapeutics Inc.
Companies
- EyePoint PharmaceuticalsChief executive officer Jul 12, 2023 to now1
- EyePoint PharmaceuticalsPresident Jan 10, 2023 to now2
- EyePoint PharmaceuticalsBoard member Sep 27, 2016 to now3
- EyePoint PharmaceuticalsChief operating officer Nov 3, 2021 to Jun 22, 20234
- Carisma Therapeutics Inc.Board member Jan 22, 2015 to Jun 24, 20225
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- EyePoint Pharmaceuticals EYPT187,025 shares6$78.8K at $0.42Jul 14, 2026
- Carisma Therapeutics Inc.40,000 shares7Jun 22, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Jul 10, 2026Shares withheld for tax 8,059 shares at $14.72 of EyePoint Pharmaceuticals6
- Jul 10, 2026Exercised options 16,667 shares of EyePoint Pharmaceuticals6
- Mar 23, 2026Other 76,766 shares at $13.11 of EyePoint Pharmaceuticals8
- Mar 23, 2026Other 76,766 shares at $13.11 of EyePoint Pharmaceuticals8
- Mar 16, 2026Bought 1,500 shares at $13.15 of EyePoint Pharmaceuticals9
- Jan 6, 2026Shares withheld for tax 10,054 shares at $16.86 of EyePoint Pharmaceuticals10
- Jan 6, 2026Exercised options 20,793 shares of EyePoint Pharmaceuticals10
- Jan 5, 2026Shares withheld for tax 14,505 shares at $17.43 of EyePoint Pharmaceuticals11
- Jan 5, 2026Exercised options 30,000 shares of EyePoint Pharmaceuticals11
- Jan 3, 2026Shares withheld for tax 23,447 shares at $17.48 of EyePoint Pharmaceuticals11
- Jan 3, 2026Exercised options 65,000 shares of EyePoint Pharmaceuticals11
- Jul 10, 2025Shares withheld for tax 7,688 shares at $11.06 of EyePoint Pharmaceuticals12
- Jul 10, 2025Exercised options 16,667 shares of EyePoint Pharmaceuticals12
- Jun 23, 2025Other 56,665 shares at $8.21 of EyePoint Pharmaceuticals13
- Mar 19, 2025Other 20,000 shares at $6.16 of EyePoint Pharmaceuticals14
- Feb 9, 2025Shares withheld for tax 2,055 shares at $6.50 of EyePoint Pharmaceuticals15
- Feb 9, 2025Exercised options 7,000 shares of EyePoint Pharmaceuticals15
- Jan 6, 2025Shares withheld for tax 6,108 shares at $8.68 of EyePoint Pharmaceuticals16
- Jan 6, 2025Exercised options 20,794 shares of EyePoint Pharmaceuticals16
- Jan 5, 2025Shares withheld for tax 10,007 shares at $8.26 of EyePoint Pharmaceuticals16
- Jan 5, 2025Exercised options 30,000 shares of EyePoint Pharmaceuticals16
- Jul 10, 2024Shares withheld for tax 8,059 shares at $8.69 of EyePoint Pharmaceuticals17
- Jul 10, 2024Exercised options 16,666 shares of EyePoint Pharmaceuticals17
- Feb 27, 2024Gift 2,500 shares of EyePoint Pharmaceuticals18
- Feb 27, 2024Gift 2,500 shares of EyePoint Pharmaceuticals18
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGAREyePoint Pharmaceuticals, President
- 3
- 4
- 5
- 6
- 7
- 8SEC EDGARForm 4 filed Mar 24, 2026
- 9SEC EDGARForm 4 filed Mar 16, 2026
- 10SEC EDGARForm 4 filed Jan 7, 2026
- 11SEC EDGARForm 4 filed Jan 6, 2026
- 12SEC EDGARForm 4 filed Jul 11, 2025
- 13SEC EDGARForm 4 filed Jun 25, 2025
- 14SEC EDGARForm 4 filed Mar 20, 2025
- 15SEC EDGARForm 4 filed Feb 11, 2025
- 16SEC EDGARForm 4 filed Jan 7, 2025
- 17SEC EDGARForm 4 filed Jul 12, 2024
- 18SEC EDGARForm 4 filed Feb 28, 2024